| 0.67 Delayed Data As of Nov 20 |  +0.03 / +4.69%Today’s Change | 0.64 Today|||52-Week Range 1.84 | -38.53% Year-to-Date |
| Previous close | 0.64 |
| Today’s open | 0.69 |
| Day’s range | 0.65 - 0.70 |
| Volume | 743,498 |
| Average volume (3 months) | 993,625 |
| Market cap | $76.1M |
| Earnings growth (last year) | +3.20% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -25.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.33 |
| Today’s change | Today’s % change | |
|---|---|---|
| CKPTCheckpoint Therapeut... | -0.08 | -3.43% |
| GNMXAevi Genomic Medicin... | -0.03 | -2.80% |
| INFIInfinity Pharmaceuti... | -0.05 | -3.55% |
| OTICOtonomy Inc | +0.03 | +1.28% |
| Next reporting date | March 20, 2019 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.5M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Head-Investor Relations Philip Adam Serlin |
Chief Financial Officer Mali Zeevi |
Corporate headquarters Modi'in, Tel Aviv |
